HSD3B1 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

23 results for “HSD3B1”

Trials

View all 10 →

HSD3B1 Gene Polymorphisms With Outcomes in SARS-CoV-2 Infected Patients

400 participants · First posted Aug 18, 2020

Effect of HSD3B1 (1245C) Gene Mutation on Treatment of Stage I-III Breast Cancer

62 participants · First posted Jan 11, 2022

Apalutamide and Leuprolide in Intermediate and High-risk Prostate Cancer

54 participants · First posted May 12, 2016

Drugs

HS631

11beta-HSD1 inhibitors (Galderma)

11b-HSD1 program (Cloud Pharmaceuticals)

News

HSD3B1 Gene Variant Linked to Poorer Survival in Prostate Cancer Despite Intensive Therapy

Intensified Therapy Reverses Poor Prognosis in Prostate Cancer Patients with HSD3B1 Mutation

Cross-Species Single-Cell Atlas Reveals Conserved and Divergent Programs in Mammalian Fetal Ovarian Development

Page 1 of 3